JOINT MEMORIAL · 1997–98 SESSION

HJM 4009: FDA approval of new products

Expediting the FDA's approval of new products.

Summary

  • The Washington State Legislature requests that the United States Congress enact comprehensive legislation to increase patient access to quality health care and technological innovations by insuring the rapid approval of new drugs, biological products, and medical devices without compromising patient safety or product effectiveness.

From the Senate Bill Report (HJM 4009), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · passed House, stalled in Senate
  1. IntroducedFeb 3, 1997
  2. Out of committee
  3. Passed HouseMar 13, 1997
  4. Passed Senatestopped here
  5. Filed
Prime sponsor
Mike Sherstad (R-1)
Introduced
February 3, 1997 in the House
Last action
January 30, 1998

Sponsors

Votes

House · Final Passage

March 13, 1997
Version voted on: HJM 4009
96 Yea 0 Nay 0 Absent 2 Excused
PartyYeaNayAbsentExcused
Democrat41001
Republican55001
How each member voted

Yea (96)

Excused (2)

History

The Legislature's online data doesn't include step-by-step history for sessions before 2001. Its final status is shown above, and the official bill page may have more.

HJM 4009 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page